|
SPECIALTY INJECTABLES
Specialty pharmaceuticals represent a relatively new area of prescription
medications and are accounting for a cost rising at a higher rate than regular
medications. Many of these medications and their treatments average $1,000 to
$1,500 a month per patient -the challenge lies in how to best manage utilization
of these drugs. Sophisticated advancements in new biotech injectables coupled
with the hundreds of biotech drugs in development and many of these soon to be
released, intensify the need for experienced management, distribution, and
clinical support of this program.
AmeriPharm's Specialty Injectable Pharmacy Program provides an integrated
solution for the distribution of injectable pharmaceuticals to patients and
physicians. Our team of experienced professionals provides complete drug
distribution, patient education, provider accessibility, reimbursement
services, utilization reporting and patient compliance programs.
This program is designed to lower costs for insurers, HMO's, employer groups, and health plans
while raising patient satisfaction with the highest quality, individualized
care. The system also relieves the physicians of the financial burdens
associated with inventory control and the billing of high cost injectable
therapies. Plus our clients see the significant savings gained through
AmeriPharm’s fully transparent acquisition cost based fee for service model.
Specially trained pharmacists, and certified pharmacy technicians provide the
significant care and attention needed for injectable therapy patients.
Patients, physicians and managed care organizations are enjoying the
ease-of-availability that AmeriPharm is providing for biotech pharmaceuticals.
With our extensive history in patient services, reimbursement capabilities and
prescription mail order services, AmeriPharm is meeting the challenge of
raising the quality of healthcare.
DIFFERENTIATING SERVICES
|